We are live on ! Find out more
RMTI icon

Rockwell Medical

84 hedge funds and large institutions have $133M invested in Rockwell Medical in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 30 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less funds holding

Funds holding: 8884 (-4)

10% less capital invested

Capital invested by funds: $148M → $133M (-$15M)

20% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 30

26% less call options, than puts

Call options by funds: $17.6M | Put options by funds: $23.7M

29% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 14

Holders
84
Holders Change
-4
Holders Change %
-4.55%
% of All Funds
2.41%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
10
Increased
24
Reduced
30
Closed
14
Calls
$17.6M
Puts
$23.7M
Net Calls
-$6.12M
Net Calls Change
+$4.75M
Name Holding Trade Value Shares
Change
Change in
Stake
BFA
1
BlackRock Fund Advisors
California
$12.2M -$903K -751 -8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$11.8M +$137K +114 +1%
GIM
3
Granahan Investment Management
Massachusetts
$10.1M -$491K -408 -5%
WSA
4
Wall Street Associates
California
$8.18M -$123K -102 -2%
State Street
5
State Street
Massachusetts
$7.83M -$189K -157 -3%
CS
6
Credit Suisse
Switzerland
$7.62M +$4.6M +3,827 +197%
PCM
7
Perkins Capital Management
Minnesota
$7.39M +$77K +64 +1%
EIM
8
Essex Investment Management
Massachusetts
$6.84M -$97.4K -81 -2%
BIT
9
BlackRock Institutional Trust
California
$6M +$161K +134 +3%
Northern Trust
10
Northern Trust
Illinois
$5.21M -$599K -498 -11%
CAM
11
Cormorant Asset Management
Massachusetts
$4.8M
Goldman Sachs
12
Goldman Sachs
New York
$3.24M +$1.15M +960 +64%
SCM
13
Suffolk Capital Management
New York
$2.63M -$288K -239 -11%
Morgan Stanley
14
Morgan Stanley
New York
$2.52M +$1.11M +921 +93%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$2.27M +$28.9K +24 +1%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$2.26M -$641K -533 -24%
Allianz Asset Management
17
Allianz Asset Management
Germany
$2.19M -$174K -145 -8%
Millennium Management
18
Millennium Management
New York
$2.17M +$90.2K +75 +5%
TCIM
19
TIAA CREF Investment Management
New York
$2.15M +$60.2K +50 +3%
USAA
20
United Services Automobile Association
Texas
$1.97M
BL
21
Bolton LP
Connecticut
$1.9M +$837K +696 +93%
BIM
22
BlackRock Investment Management
Delaware
$1.58M +$20.5K +17 +1%
Bank of America
23
Bank of America
North Carolina
$1.35M +$466K +387 +61%
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$1.14M -$2.4M -1,991 -70%
California State Teachers Retirement System (CalSTRS)
25
California State Teachers Retirement System (CalSTRS)
California
$893K +$37.3K +31 +5%

RMTI Hedge Fund Activity: Q2 2014 in Review

84 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Rockwell Medical (RMTI) for Q2 2014, worth a combined $133M — down 10% from $148M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of RMTI and 10 opened new positions — a net loss of 4 holders — while 30 trimmed existing stakes and 24 added.

The largest buyer was Credit Suisse, adding an estimated $4.6M. The largest seller was Invesco, exiting entirely with an estimated $4.46M sold.

  • 84 institutional investors held Rockwell Medical (RMTI) as of Q2 2014, down from 88 in Q1 2014.
  • Funds reported $133M of Rockwell Medical stock for Q2 2014, down 10% quarter-over-quarter.
  • 10 funds opened new Rockwell Medical positions in Q2 2014 and 14 closed out, a net change of -4 holders.
  • The largest Rockwell Medical buyer in Q2 2014 was Credit Suisse, an estimated $4.6M added.
  • The largest Rockwell Medical seller in Q2 2014 was Invesco, an estimated $4.46M sold.

Based on aggregated 13F filings for Q2 2014.